Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
Tumour cells exploit both genetic and adaptive means to survive and proliferate in hypoxic microenvironments, resulting in the outgrowth of more aggressive tumour cell clones. Direct measurements of tumour oxygenation, and surrogate markers of the hypoxic response in tumours (for instance, hypoxia i...
Main Authors: | Jubb, A, Buffa, F, Harris, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
by: Abu-Jamous, B, et al.
Published: (2017) -
Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia.
by: Koukourakis, M, et al.
Published: (2010) -
Targeting tumour hypoxia in breast cancer.
by: Milani, M, et al.
Published: (2008) -
Gene expression signatures as biomarkers of tumour hypoxia
by: Harris, B, et al.
Published: (2015) -
A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
by: Eustace, A, et al.
Published: (2013)